Results 171 to 180 of about 74,365 (298)

SUBDUE‐3: SUB‐urothelial DUrvalumab‐89zirconium injEction; a phase 0 biodistribution study protocol

open access: yes
BJU International, EarlyView.
Kevin G. Keane   +9 more
wiley   +1 more source

Current Knowledge on Phytoremediation Potential of Industrial Hemp (Cannabis sativa L.) for PFAS and Heavy Metal Contaminated Soils

open access: yesRemediation Journal, Volume 36, Issue 2, Spring 2026.
ABSTRACT This review synthesizes current research on the phytoremediation potential of industrial hemp (Cannabis sativa L.) for heavy metals, including arsenic, aluminium, mercury, copper, lead, cadmium, nickel, and zinc, as well as per‐ and polyfluoroalkyl substances (PFAS), commonly referred to as “forever chemicals.” A structured and transparent ...
Omid Ansari, Luca De Prato
wiley   +1 more source

Radionuclide theranostics: advances and clinical applications in lung cancer. [PDF]

open access: yesFront Oncol
Yang Y   +11 more
europepmc   +1 more source

Clinical Utility of 68Ga‐DOTATOC Positron Emission Tomography/Computed Tomography in Evaluating Metastatic Lesions of Clear Cell Renal Cell Carcinoma: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 4, July 2026.
ABSTRACT Introduction 68Ga‐DOTATOC positron emission tomography/computed tomography (PET/CT) targets somatostatin receptors (SSTRs) and is an established molecular imaging modality for neuroendocrine tumors (NETs). Although SSTR expression has been reported in renal cell carcinoma (RCC), its clinical utility remains unclear. Case Presentation A 76‐year‐
Yuta Mine   +9 more
wiley   +1 more source

Protocol‐Based Management of Medication Confounders in Brain Death Determination: A Multi‐Institutional Review

open access: yesJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Volume 9, Issue 7, July 2026.
ABSTRACT Background Determination of death by neurologic criteria (DNC) relies on clinical examination, provided no confounding conditions affect reliability. Current guidelines require patients to be free of confounders before neurologic testing but do not specify how these confounders should be assessed or managed.
Alexander Nixon   +7 more
wiley   +1 more source

Assessment of central blood volume in cirrhosis by radionuclide angiography [PDF]

open access: yes, 1994
Møgelvang, Jens   +10 more
core  

Radionuclides in Milk: A Global Systematic Review and Meta-Analysis and Probabilistic Human Risk Assessment. [PDF]

open access: yesFood Sci Nutr
Fakhri Y   +7 more
europepmc   +1 more source

Radiolabeled Angiopep‐2 Peptide Vector as a Preclinical Platform for Blood–Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice

open access: yesJournal of Peptide Science, Volume 32, Issue 7, July 2026.
The developed DOTA‐Angiopep‐2 conjugate was well tolerated in glioma cells and enabled high‐yield radiolabeling with 177Lu and 161Tb. The 161Tb conjugate showed brain delivery with predominantly renal clearance, supporting a stable radiotheranostic platform for BBB‐targeted glioma therapy and SPECT imaging.
Evgenia Fotou   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy